Lauren P. Carboni

Senior Counsel

Lauren P. Carboni

Senior Counsel

Lauren Carboni is a health care focused attorney who counsels clients across the industry on complex regulatory, compliance, litigation, and enforcement matters. Lauren represents a broad range of organizations in the health care and life sciences sector, which includes health systems, hospitals, physician groups, durable medical equipment suppliers and distributors, and others. With a litigation background and as a regulatory advisor, Lauren offers clients strategic counsel on fraud and abuse issues, regulatory risk management, internal investigations, and defense against government inquiries. She co-chairs the Health Care & Life Sciences Sector’s Health Care Litigation Area of Focus and has extensive experience with False Claims Act litigation, audits, internal investigations, risk assessments, providing health care regulatory due diligence advice on transactions, and administrative appeals involving federal and state enforcement agencies.

In addition to her robust health care practice, Lauren advises clients in the cannabis and psychedelic sectors on regulatory compliance, licensing, and business operations, with a focus on navigating the intersection of state and federal law. Her multidisciplinary perspective helps clients across highly regulated sectors address emerging risks and seize new opportunities.

Lauren is committed to providing pro bono services. She strives to represent clients in the Colorado community to ensure every person and organization, regardless of financial means, has access to the justice system. Notable pro bono successes include advocating to the parole board for the release of a disabled client from prison to obtain much-needed health care, and obtaining a settlement with a municipal police department that compensated a disabled client for injuries sustained during a traffic stop.

Awards and Recognition

  • Colorado Super Lawyers®– Rising Stars lists (2017–2020, 2022-2025), which recognizes the top 2.5 percent of Colorado lawyers under 40 years of age
  • 5280’s Denver’s Top Lawyers (2022, 2025)
  • Trial Lawyer of the Year Finalist (2017), Public Justice, for representation of an incarcerated individual challenging his conditions of confinement and access to medical care

Affiliations

  • Member, American Health Lawyers Association
  • Member, Colorado Bar Association, Health Law Section
  • Member, Colorado Women’s Bar Association
  • Member, Psychedelic Bar Association; Co-Steward of the Legislation and Regulation Committee
  • Former Member, Chanda Center for Health Board

Publications and Presentations

09 April 2025 Health Care Law Today

New Mexico Becomes Third State in the U.S. to Legalize Access to Psilocybin

On April 7, 2025, New Mexico Governor Michelle Lujan Grisham signed into law SB-219, the Medical Psilocybin Act (the Act), making New Mexico the third state in the country to create a legal pathway for patients to access psilocybin, a naturally occurring psychedelic compound produced by certain types of mushrooms.
28 January 2025 Foley Viewpoints

How Risky Are DEI Programs Under Trump 2.0?

President Trump’s January 21, 2025, executive order titled “Ending Discrimination and Restoring Merit-Based Opportunity” directs the termination of federal government practices and policies that protect and promote diversity and inclusion; the Executive Order also addresses diversity and inclusion initiatives in the private sector.
06 January 2025 Honors and Awards

Jim Miles and Lauren Carboni Named to 5280 Magazine's Denver's Top Lawyers List

Foley & Lardner LLP attorneys Jim Miles and Lauren Carboni have been named to 5280 magazine's Denver's Top Lawyers 2025 list.
29 July 2024 Health Care Law Today

Substance Use Disorder Treatment Services: 2025 Physician Fee Schedule Proposed Rule Would Expand Access and Medicare Coverage

On July 10, the Centers for Medicare & Medicaid Services released the Medicare Physician Fee Schedule Proposed Rule for the calendar year 2025.
24 April 2024 Health Care Law Today

FDA Continues to Take Stance That it Will Not Issue CBD Rules

The FDA recently doubled down on its January 26, 2023 position that existing regulatory pathways for foods and dietary supplements are not appropriate to manage the risks of CBD and a new regulatory pathway is needed.
27 February 2024 Events

Survey Enforcement Appeal Process

On February 27, Foley associate Lauren Carboni is speaking at the American Health Law Association Long Term and Post-Acute Care Law and Compliance Conference in a presentation titled “Survey Enforcement Appeal Process.”